bioRxiv / medRxiv
open access
CC BY 4.0
Variation in Tolvaptan Prescribing for Autosomal Dominant Polycystic Kidney Disease in the United Kingdom and Its Impact on Quality of Life and Costs
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Variation in Tolvaptan Prescribing for Autosomal Dominant Polycystic Kidney Disease in the United Kingdom and Its Impact on Quality of Life and Costs#157805
- Determine the Downstream Effectors of Polycystins in Autosomal Dominant Polycystic Kidney Disease#656571
- HALT Progression of Polycystic Kidney Disease Study A#125976
- Burden of chronic kidney disease and its attributable risk factors in 204 countries and territories, 1990-2021: Results from the Global Burden of Disease study 2021.#446256
- Randomized controlled trial evaluating rotigotine safety in polycystic kidney disease#326328
Record · ID 154939
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive